Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Recruiting
NCT03463317
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
1,512
Enrollment(s)
26
Study location(s)
Interventional (Phase IV)
Atrial Fibrillation
Completed
NCT00441350
Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
1,004
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Hypertension
Completed
NCT04459585
A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants
20
Enrollment(s)
1
Study location(s)
Interventional (Early Phase I)
Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib
Completed
NCT01014624
Prasugrel/Clopidogrel Maintenance Dose Washout Study
56
Enrollment(s)
4
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Not yet recruiting
NCT04719481
Pravastatin Reduces Acute Phase Response of Zoledronic Acid
110
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Postmenopausal Osteoporosis
Enrolling by invitation
NCT03271450
The DARE Warfarin CER Study
416,000
Enrollment(s)
1
Study location(s)
Observational
Deep Venous Thrombosis
Pulmonary Embolism
Completed
NCT04223635
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
16
Enrollment(s)
2
Study location(s)
Interventional (Early Phase I)
Moderate Hepatic Impairment
Completed
NCT03291288
Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
32
Enrollment(s)
11
Study location(s)
Interventional (Phase I)
Drug Interaction Potential
41
42
43
44
45